SPL

0.00%

9.9¢ starpharma holdings limited

Analysta You know my thoughts I know you are going to the AGM I...

First 3 Last

Share
Profile

Follow
antibotter

12,897 Posts.

1439

25/11/18

01:33

Post #: 36630211
Share

Originally posted by Analysta ↑

Reading your post, I’ve just had a horrible thought. Why would anyone take huge short positions that are equivalent to a week or even 2 weeks worth of ordinary trade turnover? They can’t be total novice fools, or they wouldn’t have the credit and capacity to borrow the stock.

So could it be that the numbers are grossly misreported? Or could they have inside knowledge that is leading them to bet on an apocalypse and the ability to buy all they want for a lower price? If they knew there was a catalyst to drive the market lower, they could confidently go large short and plan on making a killing. BUT they know we have 2 decent catalysts within 6 weeks (conservatively) that could easily push it to $1.80-$2.00.

The other possibility is they have inside knowledge of something such as that AZ have decided not to proceed with AZD0466 or the FDA will not approve vivagel, or that one of our big clinical trials such as Docetaxel will fail.

One last theory (a wild one) is that they are driving the price down because they are part of an imminent takeover bid, and what they lose on a $13m position is dwarfed by being able to buy the company cheaper. I feel the sp would be easily above $1.66 now if it weren’t for this activity.

This is dark stuff, but I would like a plausible answer/theory please as to why 1 or more parties would get massively short when they can’t possibly close out? And even if it’s a number of usual suspects (rather than 1 party) who short biotechs because they know so many fail, they’d still be aware that overall the stock has been shorted to a point where they’ll be trapped trying to close out. I might even ask at the AGM whether they know why the stock has been shorted to the point the shorts can’t expect to be able close out unless there’s an apocalypse for spl?

I hope I don’t sound crazy, but I got fried on a situation with Mustang where the company knew they were taking junk to a ruby auction, but told everyone they were taking quality. Of course the sp plummeted on the poor auction result, but fell more when everyone realised we’d all been misled. If something is fishy then we should not stop until we understand what’s going on.

Expand

Analysta

You know my thoughts

I know you are going to the AGM

I know you will ask the AZD0466 question

I am not interested in the other questions (licensee for USA BV formulation or Dep Docetaxel P2 clinical trial completion or FDA approval time lines)......as all three have been already answered by Dr Jackie Fairley

What I am interested in........is reason for AZD0466 delay into P1 CT......
considering what has been relayed by our CEO in two video interviews and the latest announcements

Ps.......don't forget to sit in front row

Last edited by antibotter: 25/11/18

SPL Price at posting: $1.46 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 22 more messages in this thread...

First 3 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.9¢		Change 0.000(0.00%)		Mkt cap ! $41.31M

Open	High	Low	Value	Volume
10.0¢	10.0¢	9.9¢	$14.97K	151.0K

Buyers (Bids)

No.	Vol.	Price($)
3	372123	9.9¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	5042	1

View Market Depth

No.	Vol.	Price($)
3	372123	0.099
2	140000	0.098
1	64565	0.097
1	50000	0.095
3	41738	0.094

Price($)	Vol.	No.
0.100	5042	1
0.105	137318	2
0.110	226808	10
0.115	122327	4
0.120	139405	10

Last trade - 16.10pm 27/09/2024 (20 minute delay)

SPL (ASX) Chart

Analysta You know my thoughts I know you are going to the AGM I...

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Zeta Resources seeks to resolve the Panoramic takeover story

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Analysta You know my thoughts I know you are going to the AGM I...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Zeta Resources seeks to resolve the Panoramic takeover story

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News